Reduced contrast CT lowers cost, risk in elderly patients

Article

Elderly patients can undergo CT scanning of the pancreatobiliary region with only 90% or less of the contrast dose required in other patients without compromising the exam's quality.

Elderly patients can undergo CT scanning of the pancreatobiliary region with only 90% or less of the contrast dose required in other patients without compromising the exam's quality. A lower dose could also reduce costs and the risk of complications.

Dr. Shigeki Itoh, a radiologist at Nagoya University School of Health Science in Japan, and colleagues assessed 112 patients who had undergone triple-phase contrast-enhanced CT exams on a 16-slice scanner for known or suspected pancreatobiliary disease. They split the patients into three groups according to age and weight (AJR 2006 Aug;187[2]:505-510).

The investigators found that after a 12.2% reduction in the volume and rate of contrast injection, they could achieve equivalent contrast enhancement in patients older than 60 as compared with patients aged 60 or younger undergoing scanning with a standard dose.

Recent Videos
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Pertinent Insights into the Imaging of Patients with Marfan Syndrome
What New Brain MRI Research Reveals About Cannabis Use and Working Memory Tasks
Current and Emerging Legislative Priorities for Radiology in 2025
Teleradiology and Breast Imaging: Keys to Facilitating Personalized Service, Efficiency and Equity
Radiology Study Finds Increasing Rates of Non-Physician Practitioner Image Interpretation in Office Settings
Addressing the Early Impact of National Breast Density Notification for Mammography Reports
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Improving the Quality of Breast MRI Acquisition and Processing
Related Content
© 2025 MJH Life Sciences

All rights reserved.